Actions and Detail Panel
New frontiers for evaluating evidence in medicine
Mon 20 June 2016, 09:30 – 17:30 BST
Workshop: New frontiers for evaluating evidence in medicine
Evidence-based medicine has transformed the way in which statistical evidence is used in medicine. These methods are now standard practice, routinely used by medical researchers and health policy makers to assess evidence for the effectiveness of treatments and health policies. The EBM+ consortium aims to further develop these concepts and methods. Specifically, we think that an emphasis on clinical trials as the primary source of evidence in EBM leads to an undue downgrading of alternative, potentially valuable, sources of evidence. Our goal is therefore to seek ways of integrating the results of randomized controlled trials with these other sources of evidence in a way that is useful to medical practitioners, epidemiologists, and other health officers.
This workshop will bring together scholars affiliated to the EBM+ consortium, philosophers and historians of science, as well as practitioners, to present and discuss their work and the new frontiers in the evaluation of evidence in medicine.
Andy Fugard- Lecturer in Educational Psychology Research Methods and Statistics, UCL
Donald Gillies - Emeritus Professor of Philosophy of Science and Mathematics, UCL
Federica Russo - Assistant Professor at the University of Amsterdam
Malcolm Galloway - Consultant neuropathologist, UCL Hospitals NHS
Beth Shaw - Chair, GIN AID Knowledge Working Group, NICE
Jeffrey Aronson - Consultant Physician and Clinical Pharmacologist, Department of Primary Care Health Sciences; University of Oxford
The workshop will take on Monday, 20 June 2016, from 9:30 – 17:30, at University College London, Room Darwin B05, Darwin Building, Gower Street, London , WC1E 6BT, London.
Attendance is free but space is limited. To avoid disappointment, please register on this page.